United Therapeutics (UTHR) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
In a bold move, the Company has announced a lawsuit against the FDA regarding a dispute over Liquidia Technologies, Inc.’s attempt to expand the use of its treprostinil product for treating pulmonary hypertension in patients with interstitial lung disease. This legal battle could have significant implications for both companies and the pharmaceutical industry at large.
For further insights into UTHR stock, check out TipRanks’ Stock Analysis page.
